Instituto de Oncologia Pediatrica - GRAACC - Unifesp ( Site 0205)

São Paulo 04039-001

0 studies enrolling now · 1 studies all time

What they study most

Clostridium Difficile Infection

Studies at this site

• Bezlotoxumab (MK-6072) Versus Placebo in Children With Clostridium Difficile Infection (CDI) (MK-6072-001) — Completed